Clinical Trial Update: CD70-targeted immunoPET Imaging of Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on CD70-targeted immunoPET imaging for kidney cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• CD70-targeted immunoPET imaging agent

Snippet

Sponsor: RenJi Hospital | Conditions: Urologic Neoplasms, Urogenital Neoplasms | Phase 2 | Status: RECRUITING